Circulating tumor DNA-guided treatment decision in metastatic castration-resistant prostate cancer patients: a cost-effectiveness analysis by Catharina J. P. Op ’t Hoog, Sabien J. E. Bosman, Emmy Boerrigter, Niven Mehra, Inge M. van Oort, Nielka P. van Erp, Wietske Kievit

Get full text

Whole genome sequencing of 378 prostate cancer metastases reveals tissue selectivity for mismatch deficiency with potential therapeutic implications by Daniel J. Vis, Sander A. L. Palit, Marie Corradi, Edwin Cuppen, Niven Mehra, Martijn P. Lolkema, Lodewyk F. A. Wessels, Michiel S. van der Heijden, Wilbert Zwart, Andries M. Bergman

Get full text

The Conundrum of Treating de novo metastatic Hormone-Sensitive Prostate Cancer by Tessa van Elst, Niven Mehra, Sjaak Bloem, André N. Vis, Bart P. Wijsman, Daphne Luijendijk-de Bruin, Joyce M. van Dodewaard-de Jong, Pieter L. van den Berg, Jules Lavalaye, Shafak Aluwini, Derya Yakar, Daniela E. Oprea-Lager, Peter F. A. Mulders, Haiko J. Bloemendal, Jean-Paul A. van Basten

Get full text

PD-L1 quantification across tumor types using the reverse phase protein microarray: implications for precision medicine by Mariaelena Pierobon, Johann De Bono, Ruth Riisnaes, Giuseppe Giaccone, Matthew Blackburn, Lance Liotta, Vienna Ludovini, Neil J Shah, Giuseppina Improta, Antonella Ravaggi, Niven Mehra, Angelo Sidoni, Elisa Baldelli, K Alex Hodge, Guido Bellezza, Guido Gambara, Martina Mandarano, Chamodya Ruhunusiri, Bryant Dunetz, Maysa Abu-Khalaf, Julia Wulfkuhle, Rosa I Gallagher, Franco Odicino, Maria Isabella Sereni, Angela Zupa, Perry Demsko, Lucio Crino', Emanuel F Petricoin

Get full text

Pembrolizumab after platinum-based chemotherapy for metastatic urothelial cancer: comparison between patients from a Dutch nationwide cohort and KEYNOTE-045 by Anke Richters, Britt Suelmann, Mira Franken, Niven Mehra, Bart Rikhof, Hans Westgeest, Katja Aben, Debbie Robbrecht, Lambertus Kiemeney, Joost Boormans, Toine van der Heijden, Richard Meijer, Tom Arends, Saskia van der Meer, Filip Delaere, André Vis, Carl Wijburg, Ilze van Onna, Diederik Somford, Bart Wijsman, Thomas Kerkhofs, Joan van den Bosch, Annemarie Leliveld-Kors, Katja Goossens- van der Laan, Gerd-Jan Molijn, Luc Roelofs, Martijn Steffens, Tom Hermans, Marleen Duizer

Get full text

How Does Routine Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Modify the Current Management of Prostate Cancer? A Multidisciplinary View by Daniela E. Oprea-Lager, Tessa van Elst, Shafak Aluwini, Els Dewulf, Henk van der Poel, Herman Stoevelaar, Chris H. Bangma, Aart Beeker, Steve Boudewijns, Tom Budiharto, Igle-Jan de Jong, Kim C. de Vries, Maarten L. Donswijk, Jurgen J. Fütterer, Paul Hamberg, Linda Heijmen, Robert J. Hoekstra, Thomas M.A. Kerkhofs, Jules Lavalaye, Daphne Luijendijk-de Bruin, Walter Noordzij, Irma M. Oving, Debbie G.J. Robbrecht, Eva E. Schaake, Addy C.M. van de Luijtgaarden, Roderick C.N. van den Bergh, Franchette van den Berkmortel, Tom van der Hulle, Johannes C.K. van der Mijn, Joyce M. van Dodewaard-de Jong, Michel van Kruchten, Pim J. van Leeuwen, Evert van Limbergen, R.Jeroen A. van Moorselaar, Inge M. van Oort, Joep G.H. van Roermund, Robert J. van Soest, Theo Veninga, André N. Vis, Jens Voortman, Peter-Paul M. Willemse, Derya Yakar, Niven Mehra

Get full text